+IPA.jpg)
Blend
CJC1295(without DAC)+IPA
Size
Research Profile
CJC1295(without DAC)+IPA
Literature-based research context for laboratory reference only.
A synergistic research blend combining CJC-1295 (without DAC) and Ipamorelin. These compounds work through complementary receptor pathways — GHRH receptor and ghrelin receptor — to produce additive GH-releasing effects with a favorable safety profile.
Selected literature
- Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism.
- Raun et al., 1998, European Journal of Endocrinology.
This page is provided for laboratory reference and literature review only. The material is not presented as a consumer product, medical treatment, diagnostic tool, or recommendation for human or animal use.
Overview
CJC1295(without DAC)+IPA is presented here as a laboratory reference entry. The Research Profile summarizes literature-based biological context, while this Overview documents the identity record, specification set, preparation format, and quality-reference information available on the page.
The identity block lists a blend identity rather than a single CAS number, molecular formula Blend, and molecular weight Blend. The material record is paired with ≥99% purity information and a lyophilized presentation for reference review.
Available specification labels include 10mg. The active selection is 10mg; changing the selector updates the visible specification label and COA lot references while preserving the same research-reference context.
For the active selection, the page currently shows 1 active COA lot reference. COA links, when present, are retained for batch-level purity, identity, and quantity review, while packaging and storage details remain separated in Structure & Identity.